XPH (XPH) Stock Price & Analysis
XPH (XPH) fell 0.79% to USD 67.95 as of July 25, 2026 at 13:45 UTC, according to Nexqual real-time market data.
XPH last closed at USD 68.49; the session ranged USD 67.5–68.24 on volume of 38,830 shares. Market capitalization is —, with a 52-week range of USD 40.8–70.15 (PCX). Source: Nexqual, July 25, 2026 at 13:45 UTC.
Key Statistics (as of July 25, 2026 at 13:45 UTC)
| Price | USD 67.95 |
|---|---|
| Change | ▼ 0.79% (down) |
| Previous Close | USD 68.49 |
| Open | USD 68.73 |
| Day Range | USD 67.5 – 68.24 |
| 52-Week Range | USD 40.8 – 70.15 |
| Volume | 38,830 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (XPH)
Nexqual's technical model rates XPH "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 13:45 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.97 (neutral) |
| vs SMA50 | Above (USD 62.43) |
| MACD | 1.59 (positive) |
Financial Health Score (XPH)
Nexqual rates XPH's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 13:45 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IHE | iShares U.S. Pharmaceutical ETF | USD 102.38 | ▲ 1.73% |
| PJP | Invesco Pharmaceuticals ETF | USD 120.37 | ▲ 1.33% |
| XHS | State Street SPDR S&P Health Ca | USD 132.82 | ▼ 0.09% |
| XHE | State Street SPDR S&P Health Ca | USD 85.18 | ▲ 0.02% |
| XES | State Street SPDR S&P Oil & Gas | USD 113.01 | ▼ 2.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:45 UTC. This page is informational and not investment advice.